| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06384222 | Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring… | High Risk Prostate Carcinoma | Recruiting |
| NCT05746208 | Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors | Neuroendocrine Tumors | Recruiting |
| NCT03933670 | Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on… | Prostate Adenocarcinoma | Recruiting |
| NCT04346225 | Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in… | Prostate Cancer | Recruiting |
| NCT04258462 | Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With… | Benign Kidney Neoplasm | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT05599048 | Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors | Advanced Solid Tumor | Recruiting |
| Phase 1 | |||
| NCT03830151 | Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors | Primary Brain Neoplasm | Recruiting |
| NCT03324360 | Role of Hyperpolarized 13C-Pyruvate MR Spectroscopy in Patients With Intracranial… | Brain Metastases | Recruiting |
| NCT04540107 | Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade… | Recurrent World Health Organization (WHO) Grade II Glioma | Recruiting |
| NCT04589624 | An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With… | Thyroid Gland Carcinoma | Recruiting |
| Early Phase 1 | |||
| NCT02526368 | Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer | Prostate Cancer | Recruiting |
| Not specified | |||
| NCT03067467 | Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic… | Brain Tumor Adult | Recruiting |